Actinium Pharmaceuticals reported $5.78M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
AbbVie USD 10.27B 1000K Jun/2026
Actinium Pharmaceuticals USD 5.78M 1.72M Sep/2025
Amgen USD 11.69B 6.9B Jun/2026
Bioline Rx USD 3.48M 99K Mar/2026
Capricor Therapeutics USD 29.16M 2.87M Dec/2025
Pfizer USD 85.19B 4.91B Jun/2026